SEC Form 4 · accession 0000950142-16-004306
Zeltiq Aesthetics Inc · ZLTQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew N Schiff
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 12, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 11, 2016 | S | 269,231 | $36.367 | D | 1,828,511 | I | By Aisling Capital III, L.P. |
| Common StockF4,F3 | Aug 11, 2016 | S | 230,769 | $36.417 | D | 1,597,742 | I | By Aisling Capital III, L.P. |
| Common StockF1 | holding | — | — | — | 13,137 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 7,455 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") and 5,682 restricted stock units. Each restricted stock unit represents a contingent right to receive one share. The restricted stock units vest in 12 ratable monthly installments on the 16th of each month, beginning on July 16, 2016, subject to Mr. Schiff's continued service with the Issuer, and upon vesting Mr. Schiff receives shares of Common Stock. Such shares of Common Stock include 87 shares of Common Stock held by a trust for the benefit of Mr. Schiff's children.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.22 to $38.05, inclusive. The reporting person undertakes to provide to Zeltiq Aesthetics Inc, any security holder of Zeltiq Aesthetics Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- F3The shares of Common Stock are directly held by Aisling Capital III, LP ("Aisling") and are indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III, LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Andrew Schiff is a member of the Board of Directors of Zeltiq Aesthetics, Inc.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.850 to $36.865, inclusive. The reporting person undertakes to provide to Zeltiq Aesthetics Inc, any security holder of Zeltiq Aesthetics Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.